While COVID-19 has caused many events to be rescheduled, a highly anticipated and sought after American Academy of Stem Cell Physicians (AASCP) meeting is back by popular demand. Over August 1-2, 2020, the AASCP will host its first virtual congress, allowing for wide-scale participation at an unprecedented scale. The Academy is expecting 5,000 attendees, as the program will be broadcasting internationally.
Due to COVID-19, the meeting will take place virtually. This is an effective way to ensure that everyone that wishes to participate―including those who cannot travel―can be involved. It will be readily accessible and economical, so that students, educators and physicians will not miss out on all the important topics that AASCP has in the pipeline.
Over August 1-2, 2020, the AASCP will present virtual interactive workshops that feature small participant-to-instructor ratios with a customized curriculum focusing on developing hands-on skills. Each technique will be taught by experts in the field, using didactic sessions with dynamic multimedia presentations, live demonstrations and scanning on live model, as well as phantoms.
Importantly, lecturers will demonstrate the techniques that they speak about with patients who are brought into their office on video.
Topics will include a Safety Standards Panel session, as well as:
- Sphenopalatine Ganglion Treatment
- Management of COVID-19 by Photodynamic Viral Inactivation
- Caudal Block Applications, Benefits
- Indications and Diagnosis and Treatment of Extra-articular Pain in Regenerative Medicine
- Other Critical Topics
The importance of this virtual conference coincides with the rapid growth of the global regenerative medicine market. Factors driving the growth of the market are an aging populations in key markets worldwide, an increasing prevalence of degenerative and chronic diseases, the use of cell therapies in the treatment of COVID-19 complications, and the potential for regenerative medicine to change the future of human health.
AASCP Scientific Congress and Safety Workshop
According to AASCP, if you are using biologics in your practice, whether you are using SVF, PRP, bone marrow, UCB, amniotic products, exosomes, xenografts, or peptides, there are key considerations to take into account to achieve the best safety for your patients.
Please do not miss the AASCP FDA Safety Standards panel discussion, this August 1, 2020.
The panel will discuss FDA safety standards within the industry and the AASCP offers many recommendations. One for example is communication with the Chief Scientific Officer (CSO) from the laboratory you work with. AASCP advises that talking to a sales agent is not sufficient when determining the quality of products for your patients. Sales agents typically do not have a medical or scientific background.
As shared by the spokesman for the AASCP, Dr. AJ Farshchian:
“The American Academy of Stem Cell Physicians is a group of physicians, scientists and researchers who collectively represent the most authoritative non-federal group advocating for guidelines and education on stem cell therapy and regenerative medicine. AASCP members are experts within all fields of stem cell therapy from: SVF, BM, UCB, Exosomes, Peptides, Xenografts, Allografts and Amniotic Fluids and are considered the most experienced leaders for proper advocacy in the field.”
Dr. Farshchian explains, “We will duplicate everything we did in our past meetings such as offer 8 CME credits, have lectures, workshops, discuss FDA safety Standards, have board examinations and a virtual graduation ceremony. AASCP is offering this virtual meeting so that nobody misses out on the education.”
About the American Academy of Stem Cell Physicians (AASCP)
The American Academy of Stem Cell Physicians (AASCP) is a non-profit organization created to advance research and the development of therapeutics in regenerative medicine, including diagnosis, treatment, and prevention of disease related to or occurring within the human body. Secondarily, the AASCP aims to serve as an educational resource for physicians, scientists, and the public in diseases that can be caused by physiological dysfunction that is ameliorable to medical treatment.
Registration is open for the August 1-2, 2020, event, and limited space is available on a first-come, first-serve basis. 8 CME credits can be earned.
For further information, please contact Marie Barba at AASCP 305-891-4686 or visit www.aascp.net.
Source: American Academy of Stem Cell Physicians